Merrimack Pharmaceuticals Inc (NASDAQ:MACK) - Share price - Overview

Stock Report

Merrimack Pharmaceuticals Inc MACK

Last Price
$12.18

Day Change
0.43|3.66%

As of 20/11/2017
16:57:10 EST | USD
Minimum 15 Minutes Delay.

Last Close11.75
Day Range11.73 - 12.28
Mkt Cap162.40Mil
52-Wk Range11.14 - 65.90
Yield %-
ISINUS5903282094
Volume233,050
P/E-1.62
P/S-
P/CF-1.05

Share Price

Financials
201420152016
More ...
Income Statement
Revenue102.7689.26144.27
Operating Income-66.26-129.57-110.14
Net Income-83.29-147.96-151.74
Basic EPS-8.00-13.30-12.10
Avg. Diluted Shares Outstanding101113
Balance Sheet
Current Assets132.10201.3957.44
Non Current Assets26.5633.4924.05
Total Assets158.66234.8881.48
Current Liabilities111.14103.7588.22
Total Liabilities260.80418.81332.60
Total Equity-102.14-183.93-251.12
Cash Flow
Operating Cash Flow-34.81-105.36-170.24
Capital Expenditure-6.04-12.79-3.16
Free Cash Flow-40.84-118.15-173.40

In millions, except "Basic EPS". Currency is USD.

Company Profile

Merrimack Pharmaceuticals Inc is a biotechnology company. It discovers, develops, and commercializes innovative medicines consisting of novel therapeutics paired with diagnostics to treat various types of cancer.

Sector

Healthcare

Industry

Biotechnology

Stock Style

Small-Value

Fiscal Year Ends

December

Employees

80
Key Stats
More ...
Price/Earning TTM0.34
Price/Book1.40
Price/Sales TTM1.02
Rev Growth (3 year avg)44.53
EPS Growth (3 year avg)-
Operating Margin % TTM-76.34
Net Margin % TTM-105.18
ROE TTM-
Debt/Equity-
Dividends
PreviousLatest
More ...
Declared Datet.b.c.05/04/17
Ex-Divt.b.c.30/05/17
Paidt.b.c.26/05/17
Amnt0.0010.60
AJ Bell includes AJ Bell Holdings Limited and its wholly owned subsidiaries. AJ Bell Management Limited and AJ Bell Securities Limited are authorised and regulated by the Financial Conduct Authority. All companies are registered in England and Wales at 4 Exchange Quay, Salford Quays, Manchester M5 3EE. AJ Bell procures the provision of the Morningstar Licensed Tools on an “as is” basis and does not guarantee the performance of or accept liability for the Licensed Tools. To the maximum extent permitted by law, AJ Bell excludes liability for the Licensed Tools, including liability for any failure, interruption, delay or defect in the performance of any Licensed Tool, unless it arises as a direct result of the negligence of AJ Bell.
© Copyright 2017 Morningstar. All rights reserved.